Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody | Patent Publication Number 20200095315

US 20200095315 A1
Patent NumberUS 10961307 B2
Application Number16580509
Filled DateSep 24, 2019
Priority DateSep 24, 2018
Publication DateMar 26, 2020
Original AssigneeJohnson & Johnson
Current AssigneeJohnson & Johnson
Inventor/ApplicantsJewel Johans
Hongyan Zhang
Richard Strauss
Kimberly Shields-Tuttle
Colleen Marano
Christopher O'Brien
Omoniyi Adedokun
Jewel Johanns
Katherine Li
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.